TGR Biosciences Pty Ltd is an Australian biotechnology company, founded in 2001 and headquartered in Australia. The company specializes in the development and manufacture of immunoassays and immunoassay technologies. TGR's CaptSure technology underpins its immunoassay products and is available for license. The company received a $3.00M Venture Round investment on 17 August 2005, with Kestrel Capital and Nanyang Ventures being the investors.
No recent news or press coverage available for TGR Biosciences Pty Ltd.